Life Sciences Nova Scotia
  • About
    • Who We Are
    • What we do
    • Why work in Nova Scotia?
    • Contact us
  • Members
    • Member Directory
    • Member Benefits
    • Become a member
  • Resources
    • Member Programs
    • News and success stories
    • Member Job Board
  • Events
    • Events
    • BioPort Atlantic
    • Atlantic Precision Medicine Conference
  • Podcast
Select Page

Research and innovation leading to better outcomes for Canadians living with diabetes

by administrator | May 16, 2018 | News, Novo Nordisk

See original story here In August 1922, 13-year-old Elizabeth Evans Hughes, extremely weak at only 45 pounds, was one of the first patients treated with insulin. It saved her life. She went on to graduate from college, get married and have three children. She died...

Xultophy® approved in Canada for the treatment of adults with type 2 diabetes

by administrator | Apr 18, 2018 | News, Novo Nordisk

See original story here Once-daily Xultophy® has been shown to help patients achieve blood glucose targets Novo Nordisk announced today that Health Canada has approved Xultophy®as an adjunct to lifestyle modifications, for the once-daily treatment of adults with type...

Recent Posts

  • Scotiaderm receive new funding from Natural Products Canada
  • Two people cooking in kitchen
    Province Awards Nova Scotia Lighthouse Project Funding
  • 3DBioFibR Inc. fibers being pulled
    3DBioFibR Raises $3M to Advance Next-Gen Biopolymer Fiber Manufacturing Platform
  • Logo of XO Technology
    XO Technology selected for Invest Nova Scotia’s Accelerate program
  • Establishing Canada’s first large-scale bioinnovation centre
No comments to show.

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow